1. Home
  2. FCO vs LSTA Comparison

FCO vs LSTA Comparison

Compare FCO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Global Income Fund Inc.

FCO

abrdn Global Income Fund Inc.

HOLD

Current Price

$2.84

Market Cap

43.0M

Sector

Finance

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$4.51

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCO
LSTA
Founded
N/A
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.0M
45.2M
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
FCO
LSTA
Price
$2.84
$4.51
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
157.0K
64.3K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$2.73
$1.81
52 Week High
$6.77
$5.07

Technical Indicators

Market Signals
Indicator
FCO
LSTA
Relative Strength Index (RSI) 35.04 25.72
Support Level $2.81 $4.03
Resistance Level $3.06 $5.06
Average True Range (ATR) 0.10 0.08
MACD -0.03 -0.09
Stochastic Oscillator 4.42 11.27

Price Performance

Historical Comparison
FCO
LSTA

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories: Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: